Beximco Pharmaceuticals Limited (BXP.L)
GBp 38.0
(1.33%)
GBp 38.0
(1.33%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 12.95 Billion BDT | 16.44% |
| 2021 | 11.12 Billion BDT | 42.53% |
| 2020 | 7.8 Billion BDT | 16.13% |
| 2019 | 6.72 Billion BDT | 1.05% |
| 2018 | 6.65 Billion BDT | 16.21% |
| 2017 | 5.72 Billion BDT | 39.44% |
| 2016 | 4.1 Billion BDT | 21.64% |
| 2015 | 3.37 Billion BDT | 10.71% |
| 2014 | 3.04 Billion BDT | 7.12% |
| 2013 | 2.84 Billion BDT | 0.53% |
| 2012 | 2.83 Billion BDT | 8.11% |
| 2011 | 2.61 Billion BDT | 31.96% |
| 2010 | 1.98 Billion BDT | 0.95% |
| 2009 | 1.96 Billion BDT | 30.54% |
| 2008 | 1.5 Billion BDT | 2.38% |
| 2007 | 1.47 Billion BDT | -16.2% |
| 2006 | 1.75 Billion BDT | 4.2% |
| 2005 | 1.68 Billion BDT | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | 13.08 Billion BDT | -2.28% |
| 2023 Q1 | 13.32 Billion BDT | 2.85% |
| 2023 Q2 | 13.39 Billion BDT | 0.55% |
| 2022 Q2 | 13.44 Billion BDT | 7.78% |
| 2022 FY | 12.95 Billion BDT | 16.44% |
| 2022 Q4 | 12.95 Billion BDT | -2.94% |
| 2022 Q3 | 13.34 Billion BDT | -0.72% |
| 2022 Q1 | 12.47 Billion BDT | 12.11% |
| 2021 Q2 | 10.09 Billion BDT | 19.57% |
| 2021 Q3 | 10.62 Billion BDT | 5.19% |
| 2021 Q4 | 11.12 Billion BDT | 4.7% |
| 2021 FY | 11.12 Billion BDT | 42.53% |
| 2021 Q1 | 8.44 Billion BDT | 8.23% |
| 2020 Q4 | 7.8 Billion BDT | 4.17% |
| 2020 Q3 | 7.49 Billion BDT | -1.78% |
| 2020 Q2 | 7.62 Billion BDT | -0.45% |
| 2020 Q1 | 7.66 Billion BDT | 14.02% |
| 2020 FY | 7.8 Billion BDT | 16.13% |
| 2019 Q2 | 6.11 Billion BDT | -2.3% |
| 2019 Q1 | 6.26 Billion BDT | -5.84% |
| 2019 Q4 | 6.72 Billion BDT | -1.85% |
| 2019 Q3 | 6.84 Billion BDT | 11.92% |
| 2019 FY | 6.72 Billion BDT | 1.05% |
| 2018 Q2 | 6.98 Billion BDT | 8.34% |
| 2018 Q1 | 6.44 Billion BDT | 12.61% |
| 2018 Q4 | 6.65 Billion BDT | -5.86% |
| 2018 FY | 6.65 Billion BDT | 16.21% |
| 2018 Q3 | 7.06 Billion BDT | 1.18% |
| 2017 Q3 | 4.4 Billion BDT | 5.26% |
| 2017 Q2 | 4.18 Billion BDT | -2.31% |
| 2017 Q1 | 4.28 Billion BDT | 4.31% |
| 2017 FY | 5.72 Billion BDT | 39.44% |
| 2017 Q4 | 5.72 Billion BDT | 29.99% |
| 2016 Q4 | 4.1 Billion BDT | 11.81% |
| 2016 Q2 | 3.49 Billion BDT | 3.72% |
| 2016 Q3 | 3.67 Billion BDT | 5.08% |
| 2016 Q1 | 3.36 Billion BDT | -0.51% |
| 2016 FY | 4.1 Billion BDT | 21.64% |
| 2015 Q4 | 3.38 Billion BDT | 0.0% |
| 2015 Q1 | 3.4 Billion BDT | 2.17% |
| 2015 FY | 3.37 Billion BDT | 10.71% |
| 2015 Q2 | 3.37 Billion BDT | -1.02% |
| 2014 Q4 | 3.33 Billion BDT | 7.9% |
| 2014 Q3 | 3.09 Billion BDT | 1.46% |
| 2014 Q2 | 3.04 Billion BDT | 2.1% |
| 2014 Q1 | 2.98 Billion BDT | 2.57% |
| 2014 FY | 3.04 Billion BDT | 7.12% |
| 2013 Q1 | 3.1 Billion BDT | 4.1% |
| 2013 Q2 | 2.84 Billion BDT | -8.29% |
| 2013 Q3 | 2.9 Billion BDT | 2.11% |
| 2013 Q4 | 2.91 Billion BDT | 0.18% |
| 2013 FY | 2.84 Billion BDT | 0.53% |
| 2012 Q1 | 2.69 Billion BDT | 0.0% |
| 2012 Q3 | 2.85 Billion BDT | 0.74% |
| 2012 FY | 2.83 Billion BDT | 8.11% |
| 2012 Q4 | 2.98 Billion BDT | 4.52% |
| 2012 Q2 | 2.83 Billion BDT | 5.06% |
| 2011 Q2 | 2.61 Billion BDT | 7.61% |
| 2011 FY | 2.61 Billion BDT | 31.96% |
| 2011 Q1 | 2.43 Billion BDT | 0.6% |
| 2010 Q4 | 2.41 Billion BDT | 1.72% |
| 2010 Q1 | 2.27 Billion BDT | 4.33% |
| 2010 Q2 | 1.98 Billion BDT | -12.79% |
| 2010 Q3 | 2.37 Billion BDT | 19.83% |
| 2010 FY | 1.98 Billion BDT | 0.95% |
| 2009 Q1 | 1.92 Billion BDT | 1.95% |
| 2009 Q4 | 2.18 Billion BDT | -1.27% |
| 2009 Q3 | 2.2 Billion BDT | 12.37% |
| 2009 Q2 | 1.96 Billion BDT | 2.29% |
| 2009 FY | 1.96 Billion BDT | 30.54% |
| 2008 Q2 | 1.5 Billion BDT | 0.0% |
| 2008 Q4 | 1.88 Billion BDT | 0.0% |
| 2008 FY | 1.5 Billion BDT | 2.38% |
| 2007 Q2 | 1.47 Billion BDT | 0.0% |
| 2007 FY | 1.47 Billion BDT | -16.2% |
| 2007 Q4 | 1.75 Billion BDT | 0.0% |
| 2006 FY | 1.75 Billion BDT | 4.2% |
| 2005 FY | 1.68 Billion BDT | 0.0% |
| Name | Inventory | Inventory Difference |
|---|